High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$6.6M
$6,576,010
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2026-02-19
$209,763x4
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2026-02-19 | $209,763x4 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Sell to Cover
2026-02-18
$213,698
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Sell to Cover
|
2026-02-18 | $213,698 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2026-02-17
$72,266
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2026-02-17 | $72,266 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2026-02-17
$194,914x2
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2026-02-17 | $194,914x2 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2026-01-09
$180,320x3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2026-01-09 | $180,320x3 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Sell to Cover
2026-01-08
$308,760x3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Sell to Cover
|
2026-01-08 | $308,760x3 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Equity Compensation
2026-01-07
$128,626x4
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Equity Compensation
|
2026-01-07 | $128,626x4 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Sell to Cover
2026-01-07
$377,825x7
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Sell to Cover
|
2026-01-07 | $377,825x7 | S | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Sell to Cover
2026-01-06
$133,816
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Sell to Cover
|
2026-01-06 | $133,816 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2025-11-17
$72,240
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2025-11-17 | $72,240 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2025-11-17
$213,687x3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2025-11-17 | $213,687x3 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2025-10-07
$128,588
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2025-10-07 | $128,588 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2025-10-07
$214,091x3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2025-10-07 | $214,091x3 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2025-10-06
$89,326
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2025-10-06 | $89,326 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2025-10-06
$147,449
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2025-10-06 | $147,449 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2025-10-03
$893,060x3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2025-10-03 | $893,060x3 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2025-10-03
$1,491,100Largex10
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2025-10-03 | $1,491,100Largex10 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2025-09-12
$936,688x3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2025-09-12 | $936,688x3 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2025-09-12
$1,508,083Largex4
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2025-09-12 | $1,508,083Largex4 | S | Form 4 |
|
PTCT
M
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
Other
2025-09-11
$863,498x3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
Other
|
2025-09-11 | $863,498x3 | M | Form 4 |
|
PTCT
S
PTC THERAPEUTICS, INC.
Boulding Mark Elliott
• Officer • EXEC. VP AND CLO
10b5-1 Sell
2025-09-11
$1,382,504Largex3
|
||||||
| PTCT |
PTC THERAPEUTICS, INC.
|
Officer • EXEC. VP AND CLO
10b5-1 Sell
|
2025-09-11 | $1,382,504Largex3 | S | Form 4 |